You are viewing the site in preview mode

Skip to main content

Advertisement

Open Peer Review Reports for: Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
13 Jan 2018 Submitted Original manuscript
23 Jan 2018 Reviewed Reviewer Report - Franco Maggiolo
15 Mar 2018 Reviewed Reviewer Report - Vincent Soriano
26 Apr 2018 Author responded Author comments - Alberto Borghetti
Resubmission - Version 2
26 Apr 2018 Submitted Manuscript version 2
6 May 2018 Reviewed Reviewer Report - Franco Maggiolo
4 Jun 2018 Reviewed Reviewer Report - Massimiliano Lanzafame
30 Nov 2018 Author responded Author comments - Alberto Borghetti
Resubmission - Version 3
30 Nov 2018 Submitted Manuscript version 3
14 Dec 2018 Author responded Author comments - Alberto Borghetti
Resubmission - Version 4
14 Dec 2018 Submitted Manuscript version 4
18 Dec 2018 Author responded Author comments - Alberto Borghetti
Resubmission - Version 5
18 Dec 2018 Submitted Manuscript version 5
22 Dec 2018 Author responded Author comments - Alberto Borghetti
Resubmission - Version 6
22 Dec 2018 Submitted Manuscript version 6
Publishing
28 Dec 2018 Editorially accepted
17 Jan 2019 Article published 10.1186/s12879-018-3666-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement